Embryo Condition Media Collected from Polycystic Ovary Syndrome Patients with Abdominal Obesity Can Increase The Decidualization Potential of Healthy Endometrial Stromal Cells

Document Type : Original Article


1 Faculty of Development of Biology, University of Science and Culture, Tehran, Iran

2 Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

3 Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

4 Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute Academic Center for Education, Culture and Research (ACECR), Tehran, Iran


Background: Polycystic ovary syndrome (PCOS) is a common endocrinological disorder associated with abdominal
obesity (AO) and some reproductive complications including low pregnancy rate. Embryo-endometrium cross-talk
has a key role in successful embryo implantation and subsequent normal pregnancy rate. The primary objective of
this study is to evaluate the decidualization potential of endometrial stromal cells (ESCs) using the embryo condition
media (ECM) collected from PCOS patients with AO, compared to ECM of those patients without AO.
Materials and Methods: In this experimental study, we measured the capacity of ECM collected from PCOS patients
with or without AO for decidualization induction in healthy ESCs after coculture. A total number of 53 embryos from
40 couples belonging to PCOS with AO, PCOS without AO, nonPCOS with AO, and nonPCOS without AO patients,
were included in our study. The embryosof four groups were single-cultured up to the blastocyst stage. Their ECM
(45λ/well) were pooled and added to healthy ESCs monolayer culture media to investigate their effects on decidualization
potential via gene (PRL, IGFBP1, IL1-β, HOXA10, IL-6 and TNF-α) and protein (PRL, IGFBP1, IL1-β)
expression analysis and ESCs migration assay.
Results: The morphological analysis, migration assay (P≤0.0321), protein (P≤0.0139) and gene expression analysis
showed PCOS with AO accounted for the highest gene (PRL, IGFBP1, IL1-β, HOXA10, IL-6, TNF-α) and protein
markers (PRL, IGFBP1, IL1-β) (P≤0.05). NonPCOS individuals without AO had the lowest level of both gene and
protein decidualization markers (P≤0.05).
Conclusion: Considering decidualization as an inflammatory process, a higher level of decidualization markers was
associated with a higher inflammatory status created by AO and PCOS, separately. Inflammation may disrupt the process
of inflammatory to anti-inflammatory phase required for prevention of pregnancy loss, this could explain the high
rate of abortion in these cases.


Main Subjects


    1. Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020; 13(4): 261-271.
    2. Xue Z, Li J, Feng J, Han H, Zhao J, Zhang J, et al. Research progress on the mechanism between polycystic ovary syndrome and abnormal endometrium. Front Physiol. 2021; 12: 788772.
    3. Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril. 2018; 110(5): 794-809.
    4. Wang C, Wen YX, Mai QY. Impact of metabolic disorders on endometrial receptivity in patients with polycystic ovary syndrome. Exp Ther Med. 2022; 23(3): 221.
    5. Shah D, Patil M. Infertility management in lean versus obese PCOS. In: Genazzani AR, Ibáñez L, Milewicz A, Shah D, editors. Impact of polycystic ovary, metabolic syndrome and obesity on women health. Springer: 2021; 105-127.
    6. Barrea L, Frias-Toral E, Verde L, Ceriani F, Cucalón G, Garcia- Velasquez E, et al. PCOS and nutritional approaches: differences between lean and obese phenotype. Metabol Open. 2021 3; 12: 100123.
    7. Bellver J, Rossal LP, Bosch E, Zúñiga A, Corona JT, Meléndez F, et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003; 79(5): 1136-1140.
    8. Singh R, Kaur S, Yadav S, Bhatia S. Gonadotropins as pharmacological agents in assisted reproductive technology and polycystic ovary syndrome. Trends Endocrinol Metab. 2023; 34(4): 194-215.
    9. Ochoa-Bernal MA, Fazleabas AT. Physiologic events of embryo implantation and decidualization in human and non-human primates. Int J Mol Sci. 2020; 21(6): 1973.
    10. Sehring J, Beltsos A, Jeelani R. Human implantation: the complex interplay between endometrial receptivity, inflammation, and the microbiome. Placenta. 2022; 117: 179-186.
    11. Badri Seighaldehi O, Mohseni Kouchesfahani H, Nasiri N, Shahverdi M, Hezavehei M, Shahverdi A. New findings in non-invasive assessment of embryo quality. Journal of Cell and Tissue (JCT). 2021; 12(3): 206-219.
    12. Diedrich K, Fauser B, Devroey P, Griesinger G. The role of the endometrium and embryo in human implantation. Hum Reprod Update. 2007; 13(4): 365-377.
    13. Brosens JJ, Bennett PR, Abrahams VM, Ramhorst R, Coomarasamy A, Quenby S, et al. Maternal selection of human embryos in early gestation: insights from recurrent miscarriage. Semin Cell Dev Biol. 2022; 131: 14-24.
    14. Large MJ, DeMayo FJ. The regulation of embryo implantation and endometrial decidualization by progesterone receptor signaling. Mol Cell Endocrinol. 2012; 358(2): 155-165.
    15. Tamura I, Asada H, Maekawa R, Tanabe M, Lee L, Taketani T, et al. Induction of IGFBP-1 expression by cAMP is associated with histone acetylation status of the promoter region in human endometrial stromal cells. Endocrinology. 2012; 153(11): 5612-5621.
    16. Xu Y, Lu J, Wu J, Jiang R, Guo C, Tang Y, et al. HOXA10 co-factor MEIS1 is required for the decidualization in human endometrial stromal cell. J Mol Endocrinol. 2020; 64(4): 249-258.
    17. Snegovskikh V, Foyouzi N, Schatz F, Buhimschi C, Buhimschi I, Funai E, et al. IL-1 stimulates TNF production by human first trimester decidual stromal cells: Implications for implantation. Am J Obstet Gynecol. 2005; 193 Suppl 6: S175.
    18. Pathare ADS, Hinduja I, Mahadik RC. Basic aspects of endometrial receptivity in PCOS patients. Mol Biol Rep. 2022; 49(2): 1519-1528.
    19. Sieg W, Kiewisz J, Podolak A, Jakiel G, Woclawek-Potocka I, Lukaszuk J, et al. Inflammation-related molecules at the maternal-fetal interface during pregnancy and in pathologically altered endometrium. Curr Issues Mol Biol. 2022; 44(9): 3792-3808.
    20. Goto S, Kadowaki T, Hashimoto H, Kokeguchi S, Shiotani M. Stimulation of endometrium embryo transfer (SEET): injection of embryo culture supernatant into the uterine cavity before blastocyst transfer can improve implantation and pregnancy rates. Fertil Steril. 2007; 88(5): 1339-1343.
    21. Li Y, Liu S, Lv Q. Single blastocyst stage versus single cleavage stage embryo transfer following fresh transfer: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021; 267: 11-17.
    22. Franasiak JM, Alecsandru D, Forman EJ, Gemmell LC, Goldberg JM, Llarena N, et al. A review of the pathophysiology of recurrent implantation failure. Fertil Steril. 2021; 116(6): 1436-1448.
    23. Nasiri N, Babaei S, Moini A, Eftekhari-Yazdi P. Controlling semi-invasive activity of human endometrial stromal cells by inhibiting NF-kB signaling pathway using aloe-emodin and aspirin. J Reprod Infertil. 2021; 22(4): 227-240.
    24. Fathi R, Valojerdi MR, Yazdi PE, Ebrahimi B, Alipour H, Hassani F. Development of 4-cell mouse embryos after re-vitrification. Cryobiology. 2012; 64(1): 23-26.
    25. Jividen K, Movassagh MJ, Jazaeri A, Li H. Two methods for establishing primary human endometrial sromal cells from hysterectomy specimens. J Vis Exp. 2014; (87): 51513.
    26. Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES, et al. Uterine selection of human embryos at implantation. Sci Rep. 2014 Feb 6;4:3894.
    27. Siristatidis CS, Sertedaki E, Karageorgiou V, Vaidakis D. Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction. Cochrane Database Syst Rev. 2020; 8(8): CD013063.
    28. Tan IF, Lim AJ, Indran IR, Kramer MS, Yong EL. Reproductive outcomes of women with polycystic ovarian syndrome following in-vitro fertilization—a meta-analysis and systematic review. Fertility & Reproduction. 2019; 1(4): 193-201.
    29. Regidor PA, Mueller A, Sailer M, Gonzalez Santos F, Rizo JM, Egea FM. Chronic inflammation in PCOS: the potential benefits of specialized pro-resolving lipid mediators (SPMs) in the improvement of the resolutive response. Int J Mol Sci. 2020; 22(1): 384.
    30. Dabravolski SA, Nikiforov NG, Eid AH, Nedosugova LV, Starodubova AV, Popkova TV, et al. Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. Int J Mol Sci. 2021; 22(8): 3923.
    31. O'Rourke RW. Inflammation in obesity-related diseases. Surgery. 2009; 145(3): 255-259.
    32. Robertson SA, Moldenhauer LM, Green ES, Care AS, Hull ML. Immune determinants of endometrial receptivity: a biological perspective. Fertil Steril. 2022; 117(6): 1107-1120.
    33. Zhang T, Shen HH, Qin XY, Li MQ. The metabolic characteristic of decidual immune cells and their unique properties in pregnancy loss. Immunol Rev. 2022; 308(1): 168-186.
    34. Blumenfeld Z. The possible practical implication of high CRP levels in PCOS. Clin Med Insights Reprod Health. 2019; 13: 1179558119861936.
    35. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011; 1813(5): 878-888.
    36. Eser B, Islimye Taskin M, Hismiogullari AA, Aksit H, Bodur AS. The effects of IL-1A and IL-6 genes polymorphisms on gene expressions, hormonal and biochemical parameters in polycystic ovary syndrome. J Obstet Gynaecol. 2017; 37(3): 358-362.
    37. Liu H, Huang X, Mor G, Liao A. Epigenetic modifications working in the decidualization and endometrial receptivity. Cell Mol Life Sci. 2020; 77(11): 2091-2101.
    38. Zhao J, Chen Q, Xue X. An Update on the progress of endometrial receptivity in women with polycystic ovary syndrome. Reprod Sci. 2022; 29(8): 2136-2144.
    39. Sun YF, Zhang J, Xu YM, Cao ZY, Wang YZ, Hao GM, et al. High BMI and Insulin resistance are risk factors for spontaneous abortion in patients with polycystic ovary syndrome undergoing assisted reproductive treatment: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020; 11: 592495.
    40. Zhang T, Zhu W, Zhao Y, Cheung WC, Liu Y, Chen X, et al. Early transient suppression of immune checkpoint proteins T-cell immunoglobulin mucin-3 and programmed cell death-1 in peripheral blood lymphocytes after blastocyst transfer is associated with successful implantation. Fertil Steril. 2020; 114(2): 426-435.